Jafat SM,Obaid RF,Hamzah AA . .Evaluation prognostic value of serum levels of soluble programmed death protein 1 (SPD-1) in patients with rheumatoid arthritis. Biochem Cell Arch., : .
Dessie G. .2022 .Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa. PLoS One, 17(6) : .
.2021 .. , 12 : 680043.
Kadhim JR,Jabbar KD,Alosami MM,Shareef L .2022 .Medicationrelated burden among Iraqi patients with rheumatoid arthritis: An observational study. F1000Res, 10 : 1047.
Deshmukh R. . .Rheumatoid arthritis: pathophysiology, current therapeutic strategies and recent advances in targeted drug 6. , : .
.2023 .delivery system. Mater Today Commun, 10 : 105877.
Halacoglu J,Shea LA .2020 .Cardiovascular risk assessment and therapeutic implications in rheumatoid arthritis. Int J Clin Rheumatol, 13 : 878-90.
.2021 .. , 33(16) : e2100098.
Kragstrup TW,Andersen T,Heftdal LD,Hvid M,Gerwien J,Sivakumar P .2018 .The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis. Front Immunol, 9 : 2226.
.2018 .. , : .
Almeida-Santiago C,Quevedo-Abeledo JC,HernándezHernández MV,de Vera-González A,González-Delgado A,González-Gay MÁ . .Disease activity is more associated with IL-1 than with IL-6 in patients with rheumatoid arthritis. Life., : .
.2022 .. , 13(1) : 82.
Strand V,Boklage SH,Kimura T,Joly F,Boyapati A,Msihid J .2020 .High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in healthrelated quality of life for sarilumab compared with adalimumab. Arthritis Res Ther, 22 : 1-9.
Nada H,Sivaraman A,Lu Q,Min K,Kim S,Goo JI .2023 .Perspective for discovery of small molecule IL-6 inhibitors through study of structure-activity relationships and molecular docking. J Med Chem, 66(7) : 4417-33.
Ogata A,Kato Y,Higa S,Yoshizaki K. .2018 .IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol, 29(2) : 258-67.
Ibrahim RA,Al-Tae F. Interleukin RA .2021 .-6 serum level and single nucleotide gene-174 G/C promoter polymorphism in patients with rheumatoid arthritis/Iraq. , 43(2) : 164-75.
Hirano T,Yasukawa K,Harada H,Taga T,Watanabe Y,Matsuda T .1986 .Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 324(6092) : 73-6.
Jarlborg M,Gabay C .2021 .Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints. Cytokine, 149 : 155742.
Abbasifard M,Khorramdelazad H. .2020 .The bio-mission of interleukin-6 in the pathogenesis of COVID-19: a brief look at potential therapeutic tactics. Life Sci, 257 : 118097.
Aletaha D,Neogi T,Silman AJ,Funovits J,Felson DT,Bingham CO .2010 .rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum, 62(9) : 2569-81.
Bhattacharya PK,Barman B,Jamil M,Bora K. .2020 .Metabolic syndrome and atherogenic indices in rheumatoid arthritis and their relationship with disease activity: a hospital-based study from Northeast India. -0015, 8(2) : 99-105.
Jang Y,Kim T,Kim BH,Park B .2022 .Association between obesity indexes and thyroid cancer risk in Korean women: nested casecontrol study. Cancers, 14(19) : 4712.
Friedewald WT,Levy RI,Fredrickson DS .1972 .Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 18(6) : 499-502.
Alifu J,Xiang L,Zhang W,Qi P,Chen H,Liu L .2023 .Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome. Cardiovasc Diabetol, 22(1) : 255.
Hashizume M,Mihara M. .2011 .The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis. Arthritis, : 765624.
Gaber W,Azkalany GS,Gheita TA,Mohey A,Sabry R. .2012 .Clinical significance of serum interleukin-6 and−174 G/C promoter polymorphism in rheumatoid arthritis patients. Egypt Rheumatol, 11(2) : 107-13.
Koh JH,Yoon SJ,Kim M,Cho S,Lim J,Park Y .2022 .Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis. Exp Mol Med, 54(2) : 143-55.
Shaban SA .2015 .Study the serum IL-6 level between rheumatoid arthritis patients and control. Tikrit J Pure Sci, 10 : 1210-41.
Mohammed AM,Zayni SM,AL-Anee MM,Corial FI,Al-Rubaee AJ .2023 .Diagnostic and predictive values of IL-6 in a group of Iraqi patients with rheumatoid arthritis. J Fac Med Baghdad, 10(2) : .
Boyapati A,Schwartzman S,Msihid J,Choy E,Genovese MC,Burmester GR .2020 .Association of high serum interleukin‐6 levels with severe progression of rheumatoid arthritis and increased treatment response differentiating sarilumab from adalimumab or methotrexate in a post hoc analysis. Arthritis Rheumatol, 72(9) : 1456-66.
Dabeer S,Sharma N,Nagdeote A .2019 .Correlation between CRP and atherogenic index and assessment of cardiovascular disease risk in patients with rheumatic arthritis. Int J Res Rev, 6(12) : .
Cure E,Icli A,Uslu AU,Sakiz D,Cure MC,Baykara RA .2018 .Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol, 37 : 1273-80.
Çelik İE,Öztürk S,Yarlıoğlu M,Barutçu O,Akgün O,Duran M .2023 .The association between atherogenic index of plasma and no-reflow phenomenon in acute coronary syndrome. Anatol J Cardiol, 27(12) : 712.
Cure E,Cure MC .2020 .Comment on “usefulness of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?”. Adv Rheumatol, 60(1) : 23.
Meena P,Goswami S,Mathur A,Sharma R. .2021 .A study of high sensitive C-reactive protein in rheumatoid arthritis patients. Int J Res Med Sci, 10(1) : 2320-6012.